GOLDMAN SACHS GROUP INC - NEXVET BIOPHARMA PUB LTD CO ownership

NEXVET BIOPHARMA PUB LTD CO's ticker is NVET and the CUSIP is G6503X109. A total of 17 filers reported holding NEXVET BIOPHARMA PUB LTD CO in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of NEXVET BIOPHARMA PUB LTD CO
ValueSharesWeighting
Q4 2015$60,000
-6.2%
17,5780.0%0.00%
Q3 2015$64,000
-26.4%
17,578
+0.6%
0.00%
Q2 2015$87,000
-44.2%
17,479
-9.8%
0.00%
Q1 2015$156,00019,3790.00%
Other shareholders
NEXVET BIOPHARMA PUB LTD CO shareholders Q1 2015
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 874,001$2,980,0001.00%
Boxer Capital, LLC 154,840$528,0000.46%
Broadfin Capital, LLC 721,595$2,461,0000.15%
FARALLON CAPITAL MANAGEMENT LLC 2,503,696$8,538,0000.08%
ADAGE CAPITAL PARTNERS GP, L.L.C. 875,000$2,984,0000.01%
COWEN INC. 27,485$94,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 44,400$151,0000.00%
A.R.T. Advisors, LLC 13,020$44,0000.00%
NEXT Financial Group, Inc 1,300$4,0000.00%
PANAGORA ASSET MANAGEMENT INC 33,673$115,0000.00%
View complete list of NEXVET BIOPHARMA PUB LTD CO shareholders